The global market for Solutions for Biopharma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Solutions for Biopharma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Solutions for Biopharma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Solutions for Biopharma in Biotechnology Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Solutions for Biopharma include Mckesson, Cardinal Health, Definitive Healthcare, Baxter, Almac Group, SHIMADZU, SOPHiA GENETICS, PwC, QIAGEN, IQVIA Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Solutions for Biopharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solutions for Biopharma.

The Solutions for Biopharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solutions for Biopharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Solutions for Biopharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Solutions for Biopharma Market Report

Report Metric	Details
Report Name	Solutions for Biopharma Market
Segment by Type	Product Research and Discovery Clinical Trials and Development Product Cycle Management Others
Segment by Application	Biotechnology Company Pharmaceutical Company Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mckesson, Cardinal Health, Definitive Healthcare, Baxter, Almac Group, SHIMADZU, SOPHiA GENETICS, PwC, QIAGEN, IQVIA Inc, Syneos Health, BioPharma Services Inc., Getinge, Akoya Biosciences, Inc, Accenture
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solutions for Biopharma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Solutions for Biopharma Market report?

Ans: The main players in the Solutions for Biopharma Market are Mckesson, Cardinal Health, Definitive Healthcare, Baxter, Almac Group, SHIMADZU, SOPHiA GENETICS, PwC, QIAGEN, IQVIA Inc, Syneos Health, BioPharma Services Inc., Getinge, Akoya Biosciences, Inc, Accenture

What are the Application segmentation covered in the Solutions for Biopharma Market report?

Ans: The Applications covered in the Solutions for Biopharma Market report are Biotechnology Company, Pharmaceutical Company, Others

What are the Type segmentation covered in the Solutions for Biopharma Market report?

Ans: The Types covered in the Solutions for Biopharma Market report are Product Research and Discovery, Clinical Trials and Development, Product Cycle Management, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Solutions for Biopharma Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Product Research and Discovery

1.2.3 Clinical Trials and Development

1.2.4 Product Cycle Management

1.2.5 Others

1.3 Market by Application

1.3.1 Global Solutions for Biopharma Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Biotechnology Company

1.3.3 Pharmaceutical Company

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Solutions for Biopharma Market Perspective (2020-2031)

2.2 Global Solutions for Biopharma Growth Trends by Region

2.2.1 Global Solutions for Biopharma Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Solutions for Biopharma Historic Market Size by Region (2020-2025)

2.2.3 Solutions for Biopharma Forecasted Market Size by Region (2026-2031)

2.3 Solutions for Biopharma Market Dynamics

2.3.1 Solutions for Biopharma Industry Trends

2.3.2 Solutions for Biopharma Market Drivers

2.3.3 Solutions for Biopharma Market Challenges

2.3.4 Solutions for Biopharma Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Solutions for Biopharma Players by Revenue

3.1.1 Global Top Solutions for Biopharma Players by Revenue (2020-2025)

3.1.2 Global Solutions for Biopharma Revenue Market Share by Players (2020-2025)

3.2 Global Solutions for Biopharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Solutions for Biopharma Revenue

3.4 Global Solutions for Biopharma Market Concentration Ratio

3.4.1 Global Solutions for Biopharma Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Solutions for Biopharma Revenue in 2024

3.5 Global Key Players of Solutions for Biopharma Head office and Area Served

3.6 Global Key Players of Solutions for Biopharma, Product and Application

3.7 Global Key Players of Solutions for Biopharma, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Solutions for Biopharma Breakdown Data by Type

4.1 Global Solutions for Biopharma Historic Market Size by Type (2020-2025)

4.2 Global Solutions for Biopharma Forecasted Market Size by Type (2026-2031)

5 Solutions for Biopharma Breakdown Data by Application

5.1 Global Solutions for Biopharma Historic Market Size by Application (2020-2025)

5.2 Global Solutions for Biopharma Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Solutions for Biopharma Market Size (2020-2031)

6.2 North America Solutions for Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Solutions for Biopharma Market Size by Country (2020-2025)

6.4 North America Solutions for Biopharma Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Solutions for Biopharma Market Size (2020-2031)

7.2 Europe Solutions for Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Solutions for Biopharma Market Size by Country (2020-2025)

7.4 Europe Solutions for Biopharma Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Solutions for Biopharma Market Size (2020-2031)

8.2 Asia-Pacific Solutions for Biopharma Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Solutions for Biopharma Market Size by Region (2020-2025)

8.4 Asia-Pacific Solutions for Biopharma Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Solutions for Biopharma Market Size (2020-2031)

9.2 Latin America Solutions for Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Solutions for Biopharma Market Size by Country (2020-2025)

9.4 Latin America Solutions for Biopharma Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Solutions for Biopharma Market Size (2020-2031)

10.2 Middle East & Africa Solutions for Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Solutions for Biopharma Market Size by Country (2020-2025)

10.4 Middle East & Africa Solutions for Biopharma Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Mckesson

11.1.1 Mckesson Company Details

11.1.2 Mckesson Business Overview

11.1.3 Mckesson Solutions for Biopharma Introduction

11.1.4 Mckesson Revenue in Solutions for Biopharma Business (2020-2025)

11.1.5 Mckesson Recent Development

11.2 Cardinal Health

11.2.1 Cardinal Health Company Details

11.2.2 Cardinal Health Business Overview

11.2.3 Cardinal Health Solutions for Biopharma Introduction

11.2.4 Cardinal Health Revenue in Solutions for Biopharma Business (2020-2025)

11.2.5 Cardinal Health Recent Development

11.3 Definitive Healthcare

11.3.1 Definitive Healthcare Company Details

11.3.2 Definitive Healthcare Business Overview

11.3.3 Definitive Healthcare Solutions for Biopharma Introduction

11.3.4 Definitive Healthcare Revenue in Solutions for Biopharma Business (2020-2025)

11.3.5 Definitive Healthcare Recent Development

11.4 Baxter

11.4.1 Baxter Company Details

11.4.2 Baxter Business Overview

11.4.3 Baxter Solutions for Biopharma Introduction

11.4.4 Baxter Revenue in Solutions for Biopharma Business (2020-2025)

11.4.5 Baxter Recent Development

11.5 Almac Group

11.5.1 Almac Group Company Details

11.5.2 Almac Group Business Overview

11.5.3 Almac Group Solutions for Biopharma Introduction

11.5.4 Almac Group Revenue in Solutions for Biopharma Business (2020-2025)

11.5.5 Almac Group Recent Development

11.6 SHIMADZU

11.6.1 SHIMADZU Company Details

11.6.2 SHIMADZU Business Overview

11.6.3 SHIMADZU Solutions for Biopharma Introduction

11.6.4 SHIMADZU Revenue in Solutions for Biopharma Business (2020-2025)

11.6.5 SHIMADZU Recent Development

11.7 SOPHiA GENETICS

11.7.1 SOPHiA GENETICS Company Details

11.7.2 SOPHiA GENETICS Business Overview

11.7.3 SOPHiA GENETICS Solutions for Biopharma Introduction

11.7.4 SOPHiA GENETICS Revenue in Solutions for Biopharma Business (2020-2025)

11.7.5 SOPHiA GENETICS Recent Development

11.8 PwC

11.8.1 PwC Company Details

11.8.2 PwC Business Overview

11.8.3 PwC Solutions for Biopharma Introduction

11.8.4 PwC Revenue in Solutions for Biopharma Business (2020-2025)

11.8.5 PwC Recent Development

11.9 QIAGEN

11.9.1 QIAGEN Company Details

11.9.2 QIAGEN Business Overview

11.9.3 QIAGEN Solutions for Biopharma Introduction

11.9.4 QIAGEN Revenue in Solutions for Biopharma Business (2020-2025)

11.9.5 QIAGEN Recent Development

11.10 IQVIA Inc

11.10.1 IQVIA Inc Company Details

11.10.2 IQVIA Inc Business Overview

11.10.3 IQVIA Inc Solutions for Biopharma Introduction

11.10.4 IQVIA Inc Revenue in Solutions for Biopharma Business (2020-2025)

11.10.5 IQVIA Inc Recent Development

11.11 Syneos Health

11.11.1 Syneos Health Company Details

11.11.2 Syneos Health Business Overview

11.11.3 Syneos Health Solutions for Biopharma Introduction

11.11.4 Syneos Health Revenue in Solutions for Biopharma Business (2020-2025)

11.11.5 Syneos Health Recent Development

11.12 BioPharma Services Inc.

11.12.1 BioPharma Services Inc. Company Details

11.12.2 BioPharma Services Inc. Business Overview

11.12.3 BioPharma Services Inc. Solutions for Biopharma Introduction

11.12.4 BioPharma Services Inc. Revenue in Solutions for Biopharma Business (2020-2025)

11.12.5 BioPharma Services Inc. Recent Development

11.13 Getinge

11.13.1 Getinge Company Details

11.13.2 Getinge Business Overview

11.13.3 Getinge Solutions for Biopharma Introduction

11.13.4 Getinge Revenue in Solutions for Biopharma Business (2020-2025)

11.13.5 Getinge Recent Development

11.14 Akoya Biosciences, Inc

11.14.1 Akoya Biosciences, Inc Company Details

11.14.2 Akoya Biosciences, Inc Business Overview

11.14.3 Akoya Biosciences, Inc Solutions for Biopharma Introduction

11.14.4 Akoya Biosciences, Inc Revenue in Solutions for Biopharma Business (2020-2025)

11.14.5 Akoya Biosciences, Inc Recent Development

11.15 Accenture

11.15.1 Accenture Company Details

11.15.2 Accenture Business Overview

11.15.3 Accenture Solutions for Biopharma Introduction

11.15.4 Accenture Revenue in Solutions for Biopharma Business (2020-2025)

11.15.5 Accenture Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Mckesson

Cardinal Health

Definitive Healthcare

Akoya Biosciences, Inc.

Accenture Plc

BioPharma Services Inc.

List of Tables

Table 1. Global Solutions for Biopharma Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Product Research and Discovery

Table 3. Key Players of Clinical Trials and Development

Table 4. Key Players of Product Cycle Management

Table 5. Key Players of Others

Table 6. Global Solutions for Biopharma Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Solutions for Biopharma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Solutions for Biopharma Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Solutions for Biopharma Market Share by Region (2020-2025)

Table 10. Global Solutions for Biopharma Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Solutions for Biopharma Market Share by Region (2026-2031)

Table 12. Solutions for Biopharma Market Trends

Table 13. Solutions for Biopharma Market Drivers

Table 14. Solutions for Biopharma Market Challenges

Table 15. Solutions for Biopharma Market Restraints

Table 16. Global Solutions for Biopharma Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Solutions for Biopharma Market Share by Players (2020-2025)

Table 18. Global Top Solutions for Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solutions for Biopharma as of 2024)

Table 19. Ranking of Global Top Solutions for Biopharma Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Solutions for Biopharma Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Solutions for Biopharma, Headquarters and Area Served

Table 22. Global Key Players of Solutions for Biopharma, Product and Application

Table 23. Global Key Players of Solutions for Biopharma, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Solutions for Biopharma Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Solutions for Biopharma Revenue Market Share by Type (2020-2025)

Table 27. Global Solutions for Biopharma Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Solutions for Biopharma Revenue Market Share by Type (2026-2031)

Table 29. Global Solutions for Biopharma Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Solutions for Biopharma Revenue Market Share by Application (2020-2025)

Table 31. Global Solutions for Biopharma Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Solutions for Biopharma Revenue Market Share by Application (2026-2031)

Table 33. North America Solutions for Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Solutions for Biopharma Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Solutions for Biopharma Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Solutions for Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Solutions for Biopharma Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Solutions for Biopharma Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Solutions for Biopharma Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Solutions for Biopharma Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Solutions for Biopharma Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Solutions for Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Solutions for Biopharma Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Solutions for Biopharma Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Solutions for Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Solutions for Biopharma Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Solutions for Biopharma Market Size by Country (2026-2031) & (US$ Million)

Table 48. Mckesson Company Details

Table 49. Mckesson Business Overview

Table 50. Mckesson Solutions for Biopharma Product

Table 51. Mckesson Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 52. Mckesson Recent Development

Table 53. Cardinal Health Company Details

Table 54. Cardinal Health Business Overview

Table 55. Cardinal Health Solutions for Biopharma Product

Table 56. Cardinal Health Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 57. Cardinal Health Recent Development

Table 58. Definitive Healthcare Company Details

Table 59. Definitive Healthcare Business Overview

Table 60. Definitive Healthcare Solutions for Biopharma Product

Table 61. Definitive Healthcare Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 62. Definitive Healthcare Recent Development

Table 63. Baxter Company Details

Table 64. Baxter Business Overview

Table 65. Baxter Solutions for Biopharma Product

Table 66. Baxter Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 67. Baxter Recent Development

Table 68. Almac Group Company Details

Table 69. Almac Group Business Overview

Table 70. Almac Group Solutions for Biopharma Product

Table 71. Almac Group Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 72. Almac Group Recent Development

Table 73. SHIMADZU Company Details

Table 74. SHIMADZU Business Overview

Table 75. SHIMADZU Solutions for Biopharma Product

Table 76. SHIMADZU Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 77. SHIMADZU Recent Development

Table 78. SOPHiA GENETICS Company Details

Table 79. SOPHiA GENETICS Business Overview

Table 80. SOPHiA GENETICS Solutions for Biopharma Product

Table 81. SOPHiA GENETICS Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 82. SOPHiA GENETICS Recent Development

Table 83. PwC Company Details

Table 84. PwC Business Overview

Table 85. PwC Solutions for Biopharma Product

Table 86. PwC Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 87. PwC Recent Development

Table 88. QIAGEN Company Details

Table 89. QIAGEN Business Overview

Table 90. QIAGEN Solutions for Biopharma Product

Table 91. QIAGEN Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 92. QIAGEN Recent Development

Table 93. IQVIA Inc Company Details

Table 94. IQVIA Inc Business Overview

Table 95. IQVIA Inc Solutions for Biopharma Product

Table 96. IQVIA Inc Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 97. IQVIA Inc Recent Development

Table 98. Syneos Health Company Details

Table 99. Syneos Health Business Overview

Table 100. Syneos Health Solutions for Biopharma Product

Table 101. Syneos Health Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 102. Syneos Health Recent Development

Table 103. BioPharma Services Inc. Company Details

Table 104. BioPharma Services Inc. Business Overview

Table 105. BioPharma Services Inc. Solutions for Biopharma Product

Table 106. BioPharma Services Inc. Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 107. BioPharma Services Inc. Recent Development

Table 108. Getinge Company Details

Table 109. Getinge Business Overview

Table 110. Getinge Solutions for Biopharma Product

Table 111. Getinge Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 112. Getinge Recent Development

Table 113. Akoya Biosciences, Inc Company Details

Table 114. Akoya Biosciences, Inc Business Overview

Table 115. Akoya Biosciences, Inc Solutions for Biopharma Product

Table 116. Akoya Biosciences, Inc Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 117. Akoya Biosciences, Inc Recent Development

Table 118. Accenture Company Details

Table 119. Accenture Business Overview

Table 120. Accenture Solutions for Biopharma Product

Table 121. Accenture Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)

Table 122. Accenture Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Solutions for Biopharma Picture

Figure 2. Global Solutions for Biopharma Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Solutions for Biopharma Market Share by Type: 2024 VS 2031

Figure 4. Product Research and Discovery Features

Figure 5. Clinical Trials and Development Features

Figure 6. Product Cycle Management Features

Figure 7. Others Features

Figure 8. Global Solutions for Biopharma Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Solutions for Biopharma Market Share by Application: 2024 VS 2031

Figure 10. Biotechnology Company Case Studies

Figure 11. Pharmaceutical Company Case Studies

Figure 12. Others Case Studies

Figure 13. Solutions for Biopharma Report Years Considered

Figure 14. Global Solutions for Biopharma Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Solutions for Biopharma Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Solutions for Biopharma Market Share by Region: 2024 VS 2031

Figure 17. Global Solutions for Biopharma Market Share by Players in 2024

Figure 18. Global Top Solutions for Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solutions for Biopharma as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Solutions for Biopharma Revenue in 2024

Figure 20. North America Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Solutions for Biopharma Market Share by Country (2020-2031)

Figure 22. United States Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Solutions for Biopharma Market Share by Country (2020-2031)

Figure 26. Germany Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Solutions for Biopharma Market Share by Region (2020-2031)

Figure 34. China Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Solutions for Biopharma Market Share by Country (2020-2031)

Figure 42. Mexico Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Solutions for Biopharma Market Share by Country (2020-2031)

Figure 46. Turkey Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Mckesson Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 50. Cardinal Health Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 51. Definitive Healthcare Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 52. Baxter Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 53. Almac Group Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 54. SHIMADZU Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 55. SOPHiA GENETICS Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 56. PwC Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 57. QIAGEN Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 58. IQVIA Inc Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 59. Syneos Health Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 60. BioPharma Services Inc. Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 61. Getinge Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 62. Akoya Biosciences, Inc Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 63. Accenture Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions